Asked by: Beth Winter (Labour - Cynon Valley)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, what information his Department holds on the number of (a) mortgage term extensions, (b) interest-only payment switches and (c) repossessions in relation to a mortgaged property since the publication of the Mortgage Charter on 26 June 2023.
Answered by Bim Afolami - Economic Secretary (HM Treasury)
The Government’s Mortgage Charter - in addition to the significant safeguards already in place - is providing support to vulnerable households, and mortgage arrears and repossessions remain low.
On 22 March the Financial Conduct Authority published data on the uptake of the Mortgage Charter since July 2023. (https://www.fca.org.uk/data/mortgage-charter-uptake).
More broadly, there is a wide variety of data and statistics about the mortgage market in the UK available from the Bank of England (https://www.bankofengland.co.uk/statistics), the Financial Conduct Authority (https://www.fca.org.uk/data) and UK Finance (https://www.ukfinance.org.uk/data-and-research/data).
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, whether his Department has made a recent assessment of the potential impact of the Mortgage Charter on levels of (a) forbearance, (b) arrears and (c) repossessions.
Answered by Bim Afolami - Economic Secretary (HM Treasury)
The Government’s Mortgage Charter - in addition to the significant safeguards already in place - is providing support to vulnerable households, and mortgage arrears and repossessions remain low.
On 22 March the Financial Conduct Authority published data on the uptake of the Mortgage Charter since July 2023. (https://www.fca.org.uk/data/mortgage-charter-uptake).
More broadly, there is a wide variety of data and statistics about the mortgage market in the UK available from the Bank of England (https://www.bankofengland.co.uk/statistics), the Financial Conduct Authority (https://www.fca.org.uk/data) and UK Finance (https://www.ukfinance.org.uk/data-and-research/data).
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure adequate availability of (a) atomoxetine, (b) lisdexamfetamine, (c) methylphenidate and (d) other Attention Deficit Hyperactivity Disorder medication within (i) NHS Wales and (ii) Cwm Taf Morgannwg Health Board.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working hard with industry to help resolve those issues and expedite deliveries to boost supplies of medicines uses for the management of ADHD, as quickly as possible. We have been informed that these should largely be resolved by April or May 2024.
As a result of our ongoing activity and intensive work, some issues have been resolved. Certain strengths of lisdexamphetamine, guanfacine, and all strengths of atomoxetine capsules are now available. While supply issues remain for some ADHD medicines, we continue to escalate these issues with manufacturers to ensure action is taken to resolve regulatory issues and expedite deliveries, to alleviate these shortages as soon as possible.
Health is a devolved matter and as such decisions on availability of medicines in Wales are a matter for the devolved administrations. However, the Department works closely with suppliers, NHS England, the Medicines and Healthcare products Regulatory Agency, the devolved administrations, and other stakeholders to ensure patients continue to have access to the treatments they need.
The Department’s officials regularly discuss a range of issues with colleagues in the Welsh Health and Social Services, including on the access to medicines. The Department has had no specific discussions with the Welsh Minister for Health and Social Services.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 January 2024 to Question 8042 on Attention Deficit Hyperactivity Disorder: Drugs, whether it remains her Department's policy to resolve disruptions with the supply of ADHD medication by April 2024.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working hard with industry to help resolve those issues and expedite deliveries to boost supplies of medicines uses for the management of ADHD, as quickly as possible. We have been informed that these should largely be resolved by April or May 2024.
As a result of our ongoing activity and intensive work, some issues have been resolved. Certain strengths of lisdexamphetamine, guanfacine, and all strengths of atomoxetine capsules are now available. While supply issues remain for some ADHD medicines, we continue to escalate these issues with manufacturers to ensure action is taken to resolve regulatory issues and expedite deliveries, to alleviate these shortages as soon as possible.
Health is a devolved matter and as such decisions on availability of medicines in Wales are a matter for the devolved administrations. However, the Department works closely with suppliers, NHS England, the Medicines and Healthcare products Regulatory Agency, the devolved administrations, and other stakeholders to ensure patients continue to have access to the treatments they need.
The Department’s officials regularly discuss a range of issues with colleagues in the Welsh Health and Social Services, including on the access to medicines. The Department has had no specific discussions with the Welsh Minister for Health and Social Services.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with the Welsh Minister for Health and Social Services on the availability of (a) atomoxetine, (b) lisdexamfetamine, (c) methylphenidate and (d) other ADHD medication.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working hard with industry to help resolve those issues and expedite deliveries to boost supplies of medicines uses for the management of ADHD, as quickly as possible. We have been informed that these should largely be resolved by April or May 2024.
As a result of our ongoing activity and intensive work, some issues have been resolved. Certain strengths of lisdexamphetamine, guanfacine, and all strengths of atomoxetine capsules are now available. While supply issues remain for some ADHD medicines, we continue to escalate these issues with manufacturers to ensure action is taken to resolve regulatory issues and expedite deliveries, to alleviate these shortages as soon as possible.
Health is a devolved matter and as such decisions on availability of medicines in Wales are a matter for the devolved administrations. However, the Department works closely with suppliers, NHS England, the Medicines and Healthcare products Regulatory Agency, the devolved administrations, and other stakeholders to ensure patients continue to have access to the treatments they need.
The Department’s officials regularly discuss a range of issues with colleagues in the Welsh Health and Social Services, including on the access to medicines. The Department has had no specific discussions with the Welsh Minister for Health and Social Services.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Foreign, Commonwealth & Development Office:
To ask the Minister of State, Foreign, Commonwealth and Development Office, with reference to the Minister of State's oral contribution of 12 March 2024, Official Report, column 133, what assessment he has made of the adequacy of the capacity of the United Nations Relief and Works Agency to sustain the population of Gaza through delivery of aid at current volumes until the UK's next payment to the agency is due in April.
Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)
The UK provided £35 million to the United Nations Relief and Works Agency (UNRWA) this financial year, including an uplift of £16 million for the Gaza humanitarian response since 7 October, all of which was disbursed before the recent allegations came to light. No more UK funding is due this financial year.
Our decision to pause future funding to UNRWA has no impact on the UK's contribution to the humanitarian response. We remain committed to getting humanitarian aid to the people in Gaza who desperately need it. Our commitment to trebling aid to Gaza still stands. The Foreign Secretary announced a further £10 million in aid funding for the Occupied Palestinian Territories (OPTs) on 13 March, bringing the total spend to over £100 million this financial year. Together with partners we are working to get aid in as quickly as possible by land, sea and air.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Foreign, Commonwealth & Development Office:
To ask the Minister of State, Foreign, Commonwealth and Development Office, with reference to the Minister of State's oral contribution of 12 March 2024, Official Report, columns 133-34, what assessment he has made of Israel's observation of its requirements under Articles (a) 16, (b) 17 and (c) 18 of Geneva Convention (IV).
Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)
It is our position that Israel retains obligations as the Occupying Power in Gaza. Although after 2005 there was no permanent physical Israeli presence in Gaza, given the significant control Israel had over Gaza's borders, airspace and territorial waters, Israel retained obligations as an occupying power under the Fourth Geneva Convention. In situations of occupation, international humanitarian law expressly requires the occupier, to the fullest extent of the means available to it, to ensure the food and medical supplies of the population of the occupied territory. We expect Israel to fulfil its obligations and for all parties to adhere to international humanitarian law.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Foreign, Commonwealth & Development Office:
To ask the Minister of State, Foreign, Commonwealth and Development Office, with refence to the Minister of State's oral contributions of 12 March 2024, Official Report, columns 135 and 148, what assessment he has made of Israel's observation of its obligations under Article 23 of Geneva Convention (IV).
Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)
It is our position that Israel retains obligations as the Occupying Power in Gaza. Although after 2005 there was no permanent physical Israeli presence in Gaza, given the significant control Israel had over Gaza's borders, airspace and territorial waters, Israel retained obligations as an occupying power under the Fourth Geneva Convention. In situations of occupation, international humanitarian law expressly requires the occupier, to the fullest extent of the means available to it, to ensure the food and medical supplies of the population of the occupied territory. We expect Israel to fulfil its obligations and for all parties to adhere to international humanitarian law.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Foreign, Commonwealth & Development Office:
To ask the Minister of State, Foreign, Commonwealth and Development Office, with reference to the Minister of State's oral contribution of 12 March 2024, Official Report, columns 133-34, what assessment he has made of the effectiveness of the embedding of lawyers in the Israeli Defence Forces command on those forces' acceptance and honouring of international humanitarian law during the conflict in Gaza.
Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)
We have previously assessed that Israel is committed and capable of complying with International Humanitarian Law. We regularly review our assessment.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Foreign, Commonwealth & Development Office:
To ask the Minister of State, Foreign, Commonwealth and Development Office, if he will make an assessment of the implications for his policies of the difference between the average daily number of (a) aid trucks and (b) tonnes of aid that entered Gaza and the level of demand for that aid since October 2023.
Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)
There were 500 trucks entering Gaza per day before the conflict, now that number is around 150. There was a 31 per cent decrease in the average number of trucks entering Gaza daily between January (140 trucks) and February (97 trucks). The daily average for the first part of March has been around 165 trucks a day, although there is significant fluctuation from day to day.
We have been clear that Israel must take action to allow more aid into Gaza. We want to see a scale up of the Jordan corridor, with a streamlined screening and delivery process, the opening of a crossing in northern Gaza (Karni, Erez or a new crossing point), Ashdod Port fully opened for aid delivery and increased screening capacity at Kerem Shalom and Nitzana to seven days a week and extended hours.